These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2477934)

  • 1. Pharmacology and pharmacokinetics of flutamide.
    Neri R
    Urology; 1989 Oct; 34(4 Suppl):19-21; discussion 46-56. PubMed ID: 2477934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flutamide. Mechanism of action of a new nonsteroidal antiandrogen.
    Sufrin G; Coffey DS
    Invest Urol; 1976 May; 13(6):429-34. PubMed ID: 1270239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity.
    Luo S; Martel C; Chen C; Labrie C; Candas B; Singh SM; Labrie F
    Urology; 1997 Dec; 50(6):913-9. PubMed ID: 9426723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-androgenic activity of various substituted carboxyanilides].
    Varga SV; Reznikov AG; Bal'on IaG; Lozinskiĭ MO; Smirnov VA
    Probl Endokrinol (Mosk); 1983; 29(2):67-71. PubMed ID: 6856597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alpha, alpha, alpha-trifluoro-2-methyl-4'-nitro-m-lactotoluidide (Sch 16423) on serum testosterone and LH in rats.
    Clark CR; Merry BJ; Nowell NW
    J Reprod Fertil; 1981 Jan; 61(1):189-91. PubMed ID: 7452616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-androgenicity of flutamide and its metabolite Sch 16423.
    Neri R; Peets E; Watnick A
    Biochem Soc Trans; 1979 Jun; 7(3):565-9. PubMed ID: 446862
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of antiandrogens in the rat.
    Burton S; Trachtenberg J
    J Urol; 1986 Oct; 136(4):932-5. PubMed ID: 3761464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
    Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
    Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological aspects of antiandrogens.
    Neri RO; Peets EA
    J Steroid Biochem; 1975 Jun; 6(6):815-9. PubMed ID: 1177425
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental anti-androgenic activity of 4-nitro-3-trifluoromethylisobutyranilide (niftholide) in rats and guinea pigs].
    Reznikov AG; Varga SV; Demkiv LP; Bal'on IaG; Iagupol'skiĭ LM
    Farmakol Toksikol; 1977; 40(3):336-42. PubMed ID: 902725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the 5 alpha-reductase inhibitor PNU 156765, alone or in combination with flutamide, in the Dunning R3327 prostatic carcinoma model in rats.
    Zaccheo T; Giudici D; Panzeri A; di Salle E
    Chemotherapy; 1998; 44(4):284-92. PubMed ID: 9681205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of hypertrophy of the prostate of rats with 4-nitro-3-trifluoromethylisobutyranilide (Sch 13521).
    Syrkin AB; Smirnova IO; Lazarev NI
    Arzneimittelforschung; 1977 Jul; 27(7):1467-9. PubMed ID: 71154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The antiandrogenic effect of dimethachlon and its mechanism].
    Zhang GJ; Zheng YF; Zhu HJ; Zhu XQ
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Feb; 22(1):15-8. PubMed ID: 15033008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate.
    Shibata Y; Ono Y; Kashiwagi B; Suzuki K; Fukabori Y; Honma S; Yamanaka H
    Urology; 2003 Nov; 62(5):942-6. PubMed ID: 14624931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of a 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide's antiandrogenic activity.
    Yamada T; Kunimatsu T; Sako H; Yabushita S; Sukata T; Okuno Y; Matsuo M
    Toxicol Sci; 2000 Feb; 53(2):289-96. PubMed ID: 10696777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyproterone acetate in comparison to flutamide and megestrol acetate on the ventral prostate, seminal vesicle, and adrenal glands of adult male rats.
    el Etreby MF; Habenicht UF; Louton T; Nishino Y; Schröder HG
    Prostate; 1987; 11(4):361-75. PubMed ID: 2960960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine profile of Win 49596 in the rat: a novel androgen receptor antagonist.
    Snyder BW; Winneker RC; Batzold FH
    J Steroid Biochem; 1989 Dec; 33(6):1127-32. PubMed ID: 2615357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flutamide inhibits testosterone-induced masculine sexual behavior in male and female rats.
    Gladue BA; Clemens LG
    Endocrinology; 1980 Jun; 106(6):1917-22. PubMed ID: 7371596
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diethylstilbestrol potentiation of the antiandrogenic effects of niftolide in the prostate].
    Sinitsyn PV; Varga SV; Reznikov AG
    Farmakol Toksikol; 1988; 51(4):75-7. PubMed ID: 3191980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.